Neutralising antibody titres as predictors of protection against SARS-CoV-2 variants.

Pallett, Scott J C; Heskin, Joseph; Groppelli, Elisabetta; Mazzella, Andrea; Moore, Luke S P

Pallett, Scott J C; Heskin, Joseph; Groppelli, Elisabetta; Mazzella, Andrea; Moore, Luke S P.

Pallett SJC; Chelsea and Westminster Hospital NHS Foundation Trust, London SW10 9NH, UK.
Heskin J; Centre of Defence Pathology, Royal Centre for Defence Medicine, Birmingham, UK.
Groppelli E; Infection Care Group, St George's University Hospitals NHS Foundation Trust, London, UK.
Mazzella A; Chelsea and Westminster Hospital NHS Foundation Trust, London SW10 9NH, UK.
Moore LSP; Clinical Academic Group in Infection and Immunity, Institute for Infection and Immunity, St George's University of London, London, UK.

Lancet Microbe ; 3(3): e167, 2022 03.

Article in English | MEDLINE | ID: covidwho-1607039

Subject(s)

COVID-19; SARS-CoV-2; Antibodies, Neutralizing/immunology; Antibodies, Viral/immunology; Humans; SARS-CoV-2/genetics

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Prognostic study Topics: Variants Limits: Humans Language: English Journal: Lancet Microbe Year: 2022 Document Type: Article Affiliation country: S2666-5247(21)00337-2

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google